| Gene symbol | CTAG1B | Synonyms | CTAG, ESO1, CT6.1, CTAG1, LAGE-2, LAGE2B, NY-ESO-1 | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq28 | dbXrefs | |
| Description | cancer/testis antigen 1B | ||||
| GTO ID | GTC0613 |
| Trial ID | JMA-IIA00346 |
| Disease | Synovial Sarcoma |
| Altered gene | NY-ESO-1 |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | NY-ESO-1 TCR-T cells |
| HLA | HLA-A*02:01|HLA-A*02:06 |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | Investigator-initiated multi-institutional clinical trial of combination therapy of vaccination and gene-modified T cell targeting NY-ESO-1-antigen for refractory soft tissue sarcoma |
| Year | 2018 |
| Country | Japan |
| Company sponsor | Mie University Hospital |
| Vector information | |||||||
|
|||||||
| Cohort 1 | |||||||||||||||||
|
|||||||||||||||||